​

ALX Oncology (ALXO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

ALX Oncology Revenue Highlights

00

ALX Oncology Revenue by Period

ALX Oncology Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$1.18M-75.35%
2019-12-31$4.80M132.03%
2018-12-31$2.07M-

ALX Oncology generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

ALX Oncology Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$868.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.48M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$1.18100.00%
2020-09-30--100.00%
2020-06-30$527.00K-19.54%
2020-03-31$655.00K-46.00%
2019-12-31$1.21M-3.42%
2019-09-30$1.26M-3.01%
2019-06-30$1.29M25.48%
2019-03-31$1.03M-

ALX Oncology generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

ALX Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
WHWKWhitehawk Therapeutics$25.98M$7.24M
STTKShattuck Labs$5.72M-
ADVMAdverum Bio$1.00M-
GUTSFractyl Health$120.00K-
IFRXInflaRx$61.80K$36.25K
ALXOALX Oncology--
RPTXRepare Therapeutics--
ACETAdicet Bio--
PLRXPliant Therapeutics--
BMEABiomea Fusion--
IMUXImmunic--

ALXO Revenue FAQ

What is ALX Oncology’s yearly revenue?

ALX Oncology's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ALXO's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is ALX Oncology’s quarterly revenue?

ALX Oncology's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). ALXO's quarterly revenue for Q4 2024 was $868K, a 100.00% increase from the previous quarter (Q3 2024), and a -65.00% decrease year-over-year (Q4 2023).

What is ALX Oncology’s revenue growth rate?

ALX Oncology's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.